Global Neglected Tropical Diseases Diagnosis Market by Diagnostic Method (Molecular/Modern, Conventional), by Disease (Chikungunya, Dengue) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Industry Insights

In 2016, the global market for neglected tropical diseases diagnosis was valued at USD 5.3 million. Market growth is expected to be driven by formal recognition of Neglected Tropical Diseases as a global goal in the sustainable development goals. NTDs have not received the same attention and resources as other diseases like HIV or malaria in the past. They are receiving significant attention from healthcare organisations, which is expected to increase funding for R&D in diagnostic methods and treatment options.

This market will see a significant increase in the number of programs that target NTDs. To meet unmet medical needs, there is an increasing demand for sensitive and fast diagnostic tests. Although diagnostics are essential for treatment planning, there is still a gap in the treatment of NTDs and clinical diagnosis. This highlights the increasing need for appropriate diagnostic tests.

The market will also benefit from the active participation of international organizations such as PATH for accelerating the development and implementation of reliable diagnostic methods for these diseases. To combat NTDs, these organizations have formed strategic alliances to collaborate with other entities. WHO called for developing countries to spend USD 1 per person each year until 2030 in order to combat 17 NTDs. Market growth is expected to be influenced by such initiatives to improve patient outcomes.

Disease Insights

Dengue dominated this market in 2016, and it is expected to continue its dominance throughout the forecast period. Healthcare companies and institutes have been working tirelessly to create and commercialize more simple disease diagnostic platforms. In November 2014, a study was done to assess the effectiveness of dengue NS1 rapid tests and ELISA kit from multiple companies such as Bio-Rad, Alere and Alere for early diagnosis.

According to WHO updates, April 2017, dengue incidence has increased significantly in recent decades. Half of the world's population are at risk. This segment offers great growth potential, despite the fact that there are many diagnostic kits for diagnosing dengue virus.

Diagnostic Method Insights

When choosing between different diagnostic methods, specificity, sensitivity and cost-effectiveness are all factors to consider. Also, availability of skilled personnel is an important consideration. Conventional diagnostic methods rely on microscopic and macroscopic identifications of pathogens using gram stain and pathogen culturing. Biochemical methods and serology tests are also used.

This market's dominant position is due to the relative ease of accessing traditional methods across many clinics and labs. These tests are not perfect in terms of speed, timeliness, or accuracy. Rapid technological advancements are compelled to choose molecular/modern methods instead of traditional methods.

Modern diagnostic methods can overcome the limitations of accuracy and specificity. Modern assays offer many advantages, including outpatient monitoring, large screening programs for developing countries, and Point-of-care testing (POCT). This will be a powerful driver.

Service Type Insights

Numerous studies have been done to compare the effectiveness of point-of-care (POC), and this has had a positive impact on both market growth. Because of the presence of many facilities around the globe, centralized testing services held a significant share of the market. The number of centralized service centres is much higher than the number of POC centers.

The POC service market is expected to grow at an impressive rate over the forecast period. The many advantages of POCT devices such as portability, ease of use, and portability, will increase their adoption. These services also provide quick results which allow for immediate intervention or treatment, and thus, better patient outcomes. The "Chagas Detect Plus Rapid Test Kit", which was approved by the U.S. FDA, received a 510K clearance. InBios International has developed the POCT for Chagas disease. These achievements will have a significant impact on the growth of the segment during the forecast period.

End-use Insights

NTD diagnostic tools are used in a variety of healthcare settings such as hospitals, private practices and laboratories. These devices will be more widely used in the future due to rapid advancements in diagnostic tools and a high disease burden.

In 2016, the market for neglected tropical diseases diagnosis was dominated by clinical laboratories. Due to the large number of laboratories around the world, clinical laboratories emerged as the dominant end-use segment in the neglected tropical diseases diagnosis market in 2016. Due to an increase in skilled personnel within labs, this segment will continue to grow at a steady rate of CAGR over the next few years.

Over the forecast period, the Home Healthcare segment will grow at a booming rate. This is expected to be supported in part by increased use of POCT services. This segment also offers a significant benefit, including improved access to healthcare in rural and remote areas. This will drive segment growth.

Regional Insights

Nearly 150 countries have NTDs. They have also affected millions of people around the world. This disease is most prevalent in subtropical and tropical countries in Africa, Asia and Latin America. Latin America's market is expected to expand at a rapid pace. This market will grow rapidly due to the untapped potential and the increasing awareness of the Latin American population regarding how to combat NTDs.

Asia Pacific was the dominant market in 2016, taking into account diseases prevalence, availability of diagnostics, access to assays and target population. Due to the continuous improvement in healthcare infrastructure in Asian countries like India and China, the regional market will continue to hold its position through the forecast period. This market will continue to grow due to the steady growth in GDP and high prevalence of neglected tropical disease in the region.

Market Share Insights on Neglected Tropical Diseases Diagnosis

F. Hoffmann-La Roche Ltd., Abbott; Thermo Fisher Scientific, Inc., ZeptoMetrix, InBios International, Inc., Genome Diagnostics Pvt. Some of the most prominent players on the market include Omega Diagnostics Group PLC, Coris Bioconcept SPRL, DiaSys Diagnostic Systems GmbH and Oscar Medicare Pvt Ltd.

These companies are taking various strategic steps to increase their market share. These initiatives include new product development, collaborations and partnerships. Abbott recently acquired Alere, which is expected to increase the market share of the former company.

The Report Covers Certain Segments

This report provides a forecast of revenue growth at the global, regional and country level and an analysis of industry trends in each sub-segment from 2014 to 2025. Grand View Research has divided the global neglected tropical diseases diagnostic market report by disease, diagnostic method and end use.

• Disease Outlook (Revenue USD Million, 2014-2025)

  • Dengue

  • Chikungunya

  • Rabies

  • Leprosy

  • Buruli Ulcer

  • Yaws

  • Lymphatic filariasis

  • Taeniasis/Cysticercosis

  • Foodborne Trematodiases

  • Echinococcosis

  • Chagas Disease (American Trypanosomiasis).

  • Dracunculiasis

  • African Trypanosomiasis

  • Soil-transmitted Helminth Infections

  • Onchocerciasis

  • Schistosomiasis

  • Scabies and other Ectoparasites

  • Snakebite Envenoming

  • Leishmaniasis

• Diagnostic Method Outlook (Revenue USD Million, 2014-2025)

  • Conventional Method

  • Modern/Molecular Method

• Service Type Outlook (Revenue USD Millions, 2014-2025)

  • Centralized Service

  • POC Service

• End-use Outlook (Revenue USD Million, 2014-2025)

  • Clinical Labs

  • Hospitals /Clinics

  • Home Healthcare

• Regional Outlook (Revenue USD Million, 2014-2025)

  • Asia Pacific

    • India

    • China

    • Indonesia

    • Malaysia

  • Latin America

    • Brazil

    • Venezuela

    • Colombia

  • Middle East & Africa

    • Nigeria

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

Up Market Research published a new report titled “Neglected Tropical Diseases Diagnosis Market research report which is segmented by Diagnostic Method (Molecular/Modern, Conventional), by Disease (Chikungunya, Dengue), By Players/Companies Disease Outlook (Revenue USD Million 2014 - 2025)DengueChikungunyaRabiesLeprosyBuruli UlcerYawsLymphatic FilariasisTaeniasis/CysticercosisFoodborne TrematodiasesEchinococcosisChagas Disease (American Trypanosomiasis)DracunculiasisAfrican TrypanosomiasisSoil-transmitted Helminth InfectionsOnchocerciasisSchistosomiasisScabies and Other EctoparasitesSnakebite EnvenomingLeishmaniasis, Snakebite Envenoming, Taeniasis/Cysticercosis, Yaws, Schistosomiasis, Dracunculiasis, Chagas Disease (American Trypanosomiasis), Lymphatic Filariasis, Soil-transmitted Helminth Infections, Leishmaniasis, Echinococcosis, Leprosy, Dengue, Chikungunya, Scabies and Other Ectoparasites, Onchocerciasis, Rabies, Foodborne Trematodiases, African Trypanosomiasis, Buruli Ulcer”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Neglected Tropical Diseases Diagnosis Market Report Segments:

The market is segmented by Diagnostic Method (Molecular/Modern, Conventional), by Disease (Chikungunya, Dengue).

Neglected Tropical Diseases Diagnosis Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Neglected Tropical Diseases Diagnosis Market

Overview of the regional outlook of the Neglected Tropical Diseases Diagnosis Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Neglected Tropical Diseases Diagnosis Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Neglected Tropical Diseases Diagnosis Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Molecular/Modern

                2. Conventional

                1. Chikungunya

                2. Dengue

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Neglected Tropical Diseases Diagnosis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Neglected Tropical Diseases Diagnosis Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.